Position in ZTS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$348,664
-$14,355 QoQ
Shares Held
4,852
+95.6% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.20%
of 13F equity value
Holder Rank
#875
of 1,408 holders
Holding Since
Mar 2024
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ZTS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026OXFORD ASSET MANAGEMENT LLP holds $1,301,914 across 6 Drug Manufacturers - Specialty & Generic names. ZTS ranks #2 (26.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INDV |
Indivior Pharmaceuticals, Inc.
|
8,666 | $355,565 | |
| 2 | ZTS |
Zoetis Inc.
This page
|
4,852 | $348,664 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
432 | $234,070 | |
| 4 | BCRX |
Biocryst Pharmaceuticals Inc
|
17,514 | $175,140 | |
| 5 | BHC |
Bausch Health Companies Inc.
|
25,548 | $125,951 | |
| 6 | CRON |
Cronos Group Inc.
|
22,491 | $62,524 |
All Filings in ZTS
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $348,664 | 4,852 | Shares | Sole | 2026-08-14 | |
| 2025-09-30 | $363,019 | 2,481 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $218,485 | 1,401 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $278,093 | 1,689 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $974,484 | 5,981 | Shares | Sole | 2025-02-14 | |
| 2024-03-31 | $1,060,608 | 6,268 | Shares | Sole | 2024-05-15 | |
| No filing history on record for this holder in this stock. | ||||||